Y-mAbs Therapeutics, Inc. Stock, NASDAQ:YMAB
230 Park Avenue, Suite 3350, New York, New York 10169
United States of America
Number of Employees: 65
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody-based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.